Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
ABC13's Mark Spain faces a battle against Stage 4 pancreatic cancer, but he has an entire community behind him.
Nanobiotix's American depositary receipts climbed after the company completed the Phase 1 study of its pancreatic cancer treatment. The stock was up 18% at $3.55 in premarket trading. Shares had ...
FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
The therapy uses Tumor Treating Fields, or electric fields, to kill cancer cells while sparing most nearby healthy cells, ...
Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial,” published in the December 2024 issue of Oncology by ...
Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further ...
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.